Literature DB >> 20466277

Antiviral drug resistance: mechanisms and clinical implications.

Lynne Strasfeld1, Sunwen Chou.   

Abstract

Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466277      PMCID: PMC2871161          DOI: 10.1016/j.idc.2010.01.001

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  196 in total

1.  Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

Authors:  Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Wangdon Yoo; Soo-Ok Kim
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report.

Authors:  J A Kobashigawa; L W Miller; S D Russell; G A Ewald; M J Zucker; L R Goldberg; H J Eisen; K Salm; D Tolzman; J Gao; W Fitzsimmons; R First
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

3.  Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study.

Authors:  E Frobert; T Ooka; J C Cortay; B Lina; D Thouvenot; F Morfin
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

Authors:  A Marzano; M Salizzoni; W Debernardi-Venon; A Smedile; A Franchello; A Ciancio; E Gentilcore; P Piantino; A M Barbui; E David; F Negro; M Rizzetto
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

6.  Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.

Authors:  Anthony Griffiths; Shun-Hua Chen; Brian C Horsburgh; Donald M Coen
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 7.  Is combination antiviral therapy for CMV superior to monotherapy?

Authors:  W Lawrence Drew
Journal:  J Clin Virol       Date:  2006-01-18       Impact factor: 3.168

8.  Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus.

Authors:  Sunwen Chou; Gail I Marousek
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

9.  Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.

Authors:  Růzena Stránská; Rob Schuurman; Elske Nienhuis; Irma W Goedegebuure; Merjo Polman; Jan F Weel; Pauline M Wertheim-Van Dillen; Ron J M Berkhout; Anton M van Loon
Journal:  J Clin Virol       Date:  2005-01       Impact factor: 3.168

10.  Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.

Authors:  Eugene R Schiff; Ching-Lung Lai; Stefanos Hadziyannis; Peter Neuhaus; Norah Terrault; Massimo Colombo; Hans L Tillmann; Didier Samuel; Stefan Zeuzem; Leslie Lilly; Maria Rendina; Jean-Pierre Villeneuve; Nicole Lama; Craig James; Michael S Wulfsohn; Hamid Namini; Christopher Westland; Shelly Xiong; Gavin S Choy; Sally Van Doren; John Fry; Carol L Brosgart
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  27 in total

Review 1.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

Review 2.  CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.

Authors:  Lulia Koujah; Deepak Shukla; Afsar R Naqvi
Journal:  Semin Cell Dev Biol       Date:  2019-04-08       Impact factor: 7.727

Review 3.  Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.

Authors:  Aswani D Vadlapudi; Ramya K Vadlapatla; Ashim K Mitra
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-04

Review 4.  Multidrug resistance: an emerging crisis.

Authors:  Jyoti Tanwar; Shrayanee Das; Zeeshan Fatima; Saif Hameed
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-07-16

Review 5.  The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.

Authors:  Raafat El-Awady; Ekram Saleh; Amna Hashim; Nehal Soliman; Alaa Dallah; Azza Elrasheed; Ghada Elakraa
Journal:  Front Pharmacol       Date:  2017-01-10       Impact factor: 5.810

6.  Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.

Authors:  Weixu Meng; Aimin Tang; Xiaohua Ye; Xun Gui; Leike Li; Xuejun Fan; Robbie D Schultz; Daniel C Freed; Sha Ha; Dai Wang; Ningyan Zhang; Tong-Ming Fu; Zhiqiang An
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 7.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

8.  In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection.

Authors:  Edita Sarukhanyan; Sergey Shityakov; Thomas Dandekar
Journal:  ACS Omega       Date:  2018-05-16

9.  Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo.

Authors:  Daniel L Popkin; Sarah Zilka; Matthew Dimaano; Hisashi Fujioka; Cristina Rackley; Robert Salata; Alexis Griffith; Pranab K Mukherjee; Mahmoud A Ghannoum; Frank Esper
Journal:  Pathog Immun       Date:  2017-06-26

10.  Drug-resistance associated mutations in polymerase (p) gene of hepatitis B virus isolated from malaysian HBV carriers.

Authors:  Jeyanthi Suppiah; Rozainanee Mohd Zain; Salbiah Haji Nawi; Norazlah Bahari; Zainah Saat
Journal:  Hepat Mon       Date:  2014-01-05       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.